Krebs Andreas
SEC insider (Form 3/4/5 filer). CIK 0001438946. Director at Definium Therapeutics, Inc. (DFTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2026. Located in NEW YORK, NY.
Companies Krebs Andreas has filed insider reports for
- Definium Therapeutics, Inc. (DFTX): Director
Krebs Andreas
CIK: 0001438946
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (33.3%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DFTX
Definium Therapeutics, Inc.
Director
